News | October 09, 2024
Jubilant Ingrevia becomes only Indian company to join WEF’s Global Lighthouse Network
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
CSPC will receive an upfront payment of $100 million from AstraZeneca
The acquisition will strengthen the overall company’s position as leading global CRO services partner
USFDA completes PAI of Lupin’s biotech facility in Pune
Poor oral health (periodontal disease) impacts nearly 51% of Indians
Alcaftadine Ophthalmic Solution, 0.25% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
